U.S. markets closed

Global Trac Solutions Inc. (PSYC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.01040.0000 (0.00%)
At close: 3:55PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0104
Open0.0105
BidN/A x N/A
AskN/A x N/A
Day's Range0.0100 - 0.0105
52 Week Range0.0049 - 0.1800
Volume242,282
Avg. Volume1,677,908
Market Cap573,773
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    PSYC Revamps Their Online Presence with a Relaunch of Corporate Website

    LAS VEGAS, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the Company has completed the redevelopment and relaunch of its corporate website; www.globaltracsolutions.com with the intent of showcasing PSYC’s emergence as a digital media leader within the expanding medicinal psychedelic industry. Earlier this year, the Company began the process of repositioning its business plan to focus on the psychedelic sector. In managements opinion, this sector, over the past two years, has demonstrated considerable growth and momentum and has been spurred along by the Federal Drug Administration (“FDA”) granting Breakthrough Therapy status to key psychedelics such as ketamine and psilocybin.As part of its repositioning and transition, the Company, in recent months, has successfully developed and launched its two primary digital media platforms within the sector; www.psychedelicspotlight.com, and its Microdose Monthly newsletter. In addition, the Company revised its OTC Markets stock symbol to “PSYC” to reflect the Company’s intent of creating a recognizable identity within the psychedelics industry.Global Trac Solutions, Inc. CEO, David Flores stated: “With the impressive foundation we now have in place for our Psychedelic Spotlight website, dedicating time to the redevelopment of our corporate site has become a significant priority. Our reemergence in the public markets as a digital media leader in the sector of psychedelic medicine is something that I genuinely believe must be represented and communicated effectively. We have, in my opinion, placed the Company in a rather unique and potentially opportunistic position within this space and one that I intend on leveraging as I continue to focus on expanding our network and exploring new opportunities that will create value for PSYC. I genuinely believe our new Global Trac Solutions website offers a more effective presentation of our current corporate mission and initiatives as well as highlights a preeminent emphasis on transparency for the Company within the public market.”About Global Trac Solutions, Inc. (OTCPink: PSYC)At Global Trac Solutions we are integrating media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that are fostering and transforming the approach to some of society’s most pressing matters.PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.Forward-Looking Statements Disclaimer:This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19, that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.Corporate Contact:Global Trac Solutions, Inc. (PSYC) www.globaltracsolutions.com (702) 239-1919 psyc@globaltracsolutions.com OTCPINK: PSYC

  • GlobeNewswire

    PSYC’s September Newsletter Reflects Most Riveting Edition to Date and Highlights Industry Growth

    LAS VEGAS, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that as a result of the Company’s success with expanding its network within the emerging industry of medicinal psychedelics, it has effectively constructed what the Company believes to be its most compelling and dynamic newsletter to date, and further demonstrating PSYC’s continued emergence as a digital media leader within this fascinating sector. Released this morning to its growing base of subscribers, the first of its two September editions of Microdose Monthly showcases exclusive interviews with retired National Hockey League enforcer, Riley Cote, Paul F. Austin, CEO and Founder of The Third Wave, and a follow-up interview with Ronan Levy, Founder and Executive Chairman of Field Trip Health, each of which were conducted by PSYC CEO, David Flores. Also featured in the newsletter are stimulating articles written by Psychedelic Spotlight Content Director, Kent Sligh, and other content contributors whom PSYC has partnered with to cover industry-relevant subject matter.Said Global Trac Solutions, Inc. CEO, David Flores: “I truly believe that the quality of content we have been able to include in this edition of our Microdose Monthly newsletter is a reflection of the hard-work and dedication my team and I have been focused on with expanding our network and identity within the psychedelic industry. We are positively determined to establish Psychedelic Spotlight as not just a recognized brand, but a reputable source within this space that, through the engaging and knowledgeable information we develop and share, contributes to its ongoing progress and momentum. Connecting with other thought-leaders and passionate advocates within this space is, in my opinion, a critical component to our own internal growth and development. More specifically, expanding our network and establishing new connections may, in some instances, be an effective tool for exploring and identifying potential collaborative opportunities as well as other fascinating opportunities that may contribute to our growth from a monetization perspective. Fostering our development as a digital media leader in this industry is most certainly a core focus of mine currently. However, my long-term goals are far more ambitious, and I am very encouraged with the progress and direction we are moving in.”As the Company continues its efforts of expanding its development of exclusive industry-focused content, it encourages those who have not yet subscribed to Microdose Monthly to do so by visiting https://www.psychedelicspotlight.com/.About Global Trac Solutions, Inc. (OTCPink: PSYC)Global Trac Solutions is a diversified holding company dedicated to identifying new and emerging industries. By utilizing our years of business development expertise our diverse team of innovators continuously leverages our experience to effectively execute go-to-market strategies in order to position ourselves for rapid growth through the creation of an evolving business foundation to enhance profitability potential.PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.Forward-Looking Statements Disclaimer:This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.Corporate Contact:Global Trac Solutions, Inc. (PSYC) www.globaltracsolutions.com (702) 239-1919 info@globaltracsolutions.com OTCPINK: PSYC

  • GlobeNewswire

    PSYC September Newsletter to Feature Exclusive Interview with Retired NHL Heavy Hitter, Riley Cote

    LAS VEGAS, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the September 15th edition of its Microdose Monthly newsletter will be highlighted by an exclusive interview with retired National Hockey League player and medicinal psychedelic advocate, Riley Cote.In his four years with the Philadelphia Flyers, Cote developed a reputation throughout the NHL as one of the league’s most physically intimidating enforcers by racking up more than 50 on-ice fights and delivering countless bone chilling body checks to his opponents on a nightly basis. Off the ice, however, Cote found himself engaged in a fight with addiction and symptoms of PTSD that he was unable to gain an upper hand on and was steadily beginning to lose.The Psychedelic Spotlight exclusive interview and article written by PSYC CEO, David Flores, dives attentively into Cote’s road to recovery post-retirement with the help of alternative medicines and therapeutic treatments, including microdosing psilocybin. The article also covers Cote’s current and ongoing venture with BodyChek Wellness which Cote has developed to help other individuals who are facing challenges similar to those he experienced overcome them and reclaim their health in the process.Said Global Trac Solutions, Inc. CEO, David Flores: “I am incredibly grateful for this opportunity to share Riley’s story of how his mindful integration of psychedelics into his recovery process contributed to him overcoming his battle with addiction and symptoms of PTSD. In my opinion, sharing stories such as his are not only important in helping to lend credibility to the benefits of medicinal psychedelics, but also in the hope that his story may inspire others out there who may be struggling with some of the same conditions Riley was able to successfully overcome. Acknowledging that you are losing a battle with your mental health is most often the first, and most difficult, step towards recovery. And so if we in any way can help encourage or motivate individuals who may be out there struggling with their mental health to take the first step towards getting the help they need through the stories, education, and information we are providing, then we are, in my opinion, accomplishing something quite profound from a societal perspective .”Last month, the Company announced that in response to its ability to effectively increase its production of original content focused on the emerging psychedelic industry, that it’s Microdose Monthly newsletter will be distributed to subscribers on a semi-monthly basis (15th and 25th of each month). The Company encourages those who have not done so already, to subscribe to Microdose Monthly by visiting www.psychedelicspotlight.com.About Global Trac Solutions, Inc. (OTCPink: PSYC)Global Trac Solutions is a diversified holding company dedicated to identifying new and emerging industries. By utilizing our years of business development expertise our diverse team of innovators continuously leverages our experience to effectively execute go-to-market strategies in order to position ourselves for rapid growth through the creation of an evolving business foundation to enhance profitability potential.PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.Forward-Looking Statements Disclaimer:This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.Corporate Contact:Global Trac Solutions, Inc. (PSYC) www.globaltracsolutions.com (702) 239-1919 info@globaltracsolutions.com OTCPINK: PSYC